Mainz, June 12, 2013– The prestigious Marie Curie career integration fellowship grant has been awarded to TRON researcher Dr. Arbel Tadmor. The grant is given to experienced international researchers who would like to conduct their research in Europe and whose work and expertise will be a contribution to the mission and scientific success of their host organizations, and the European Union. Tadmor was selected for his proposal to investigate tumor heterogeneity at the single cell level using novel experimental and theoretical methods with the end goal of maximizing the efficacy of personalized cancer vaccines.
The grant will allow Tadmor and TRON to develop cost-effective high-throughput methods to measure the “mutanome” of hundreds of single cancer cells, integrating next-generation sequencing with microfluidics. TRON supports this project with its leading expertise in personalized cancer vaccines and unique infrastructure and resources.
Dr. Tadmor received his Ph.D. from the California Institute of Technology where he pursued novel theoretical and experimental approaches to understanding the interaction of single bacterial cells and their viruses. Prior to Caltech, Dr. Tadmor completed his studies in physics at the Weizmann Institute of Science where he worked on biophysical models of bacteria. Dr. Tadmor earned his B.A. in physics and his B.Sc. in Electrical Engineering from the Technion Institute of Technology.